Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

483

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2021

Study Completion Date

November 30, 2021

Conditions
Infant, NewbornInfant, Small for Gestational AgeInfant, Extremely Low Birth Weight
Interventions
BIOLOGICAL

Donor Milk

Donor milk provided by the Human Milk Banking Association of North America

DIETARY_SUPPLEMENT

Preterm Formula

Preterm Formula determined by center practice.

Trial Locations (17)

14642

University of Rochester, Rochester

19104

University of Pennsylvania, Philadelphia

27705

RTI International, Durham

27710

Duke University, Durham

30303

Emory University, Atlanta

35233

University of Alabama at Birmingham, Birmingham

43205

Research Institute at Nationwide Children's Hospital, Columbus

44106

Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland

46202

Indiana University, Indianapolis

48201

Wayne State University, Detroit

52242

University of Iowa, Iowa City

64108

Children's Mercy Hospital, Kansas City

75235

University of Texas Southwestern Medical Center at Dallas, Dallas

77030

University of Texas Health Science Center at Houston, Houston

87131

University of New Mexico, Albuquerque

94304

Stanford University, Palo Alto

02905

Brown University, Women & Infants Hospital of Rhode Island, Providence

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

NICHD Neonatal Research Network

NETWORK

NCT01534481 - Donor Milk vs. Formula in Extremely Low Birth Weight (ELBW) Infants | Biotech Hunter | Biotech Hunter